Hobart Private Capital’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Hobart Private Capital’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,251	Closed	-$357K	–	144
2018 Q3	$357K	Buy	2,251 +430	+24%	+$65.1K	0.27%	95
2018 Q2	$255K	Buy	+1,821	New	+$250K	0.21%	107
2018 Q1	–	Sell	-1,700	Closed	-$212K	–	118
2017 Q4	$212K	Buy	+1,700	New	+$210K	0.19%	105

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Hobart Private Capital's FBT Position: Q4 2018 in Review

Hobart Private Capital sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2018, closing a stake of 2,251 shares — an estimated $357K sold.

Hobart Private Capital first reported a position in FBT in Q4 2017 and held it in 3 quarters. The position peaked at $357K in Q3 2018. 194 funds tracked by Wall St. Rank hold FBT as of Q4 2018.

Hobart Private Capital reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2018 after selling out during the quarter.
Hobart Private Capital sold 2,251 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2018, an estimated $357K.
Hobart Private Capital first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2017 and held it in 3 quarters.
Hobart Private Capital's First Trust NYSE Arca Biotechnology Index Fund position peaked at $357K in Q3 2018.
194 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2018.

Based on Hobart Private Capital's 13F filing for Q4 2018, filed 11 Mar 2024.